Musculoskeletal Disorders of Workers in a Production and Distribution Company in Argentina
August 17, 2021 updated by: DIEGO MENDEZ, Ergosol
Musculoskeletal Disorders of Workers in a Production and Distribution Company in Argentina: a Retrospective Study
Describe musculoskeletal disorders of workers in a company in Argentina regarding working areas and demographic carachteristics of the workers.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
We are analyzing the first consultation registration of every worker that had been attended by the physiotherapist in a clinic that is located inside the company.
These records consist on demographic data and also injury related information.
Study Type
Observational
Enrollment (Actual)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Caba
-
Buenos Aires, Caba, Argentina, 1414
- Ergosol
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Workers with pain
Description
Inclusion Criteria:
- workers in a production and distribution company in Argentina that walks into the clinic inside the company
Exclusion Criteria:
- lack of registered information
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Musculoskeletal disorders
Time Frame: 21 months
|
Rate of participants with musculoskeletal disorders for each demographic characteristic.
The measurment tool will be a face-to-face questionnaire.
|
21 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Diego H Mendez, PT, Ergosol
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 15, 2019
Primary Completion (Actual)
November 30, 2020
Study Completion (Actual)
November 30, 2020
Study Registration Dates
First Submitted
October 22, 2020
First Submitted That Met QC Criteria
October 30, 2020
First Posted (Actual)
November 2, 2020
Study Record Updates
Last Update Posted (Actual)
August 18, 2021
Last Update Submitted That Met QC Criteria
August 17, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EPI01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.